Concepedia

Clinical practice considerations in facioscapulohumeral muscular dystrophy Sydney, Australia, 21 September 2015

Rabi Tawil, Jean K. Mah, Scott Baker, Kathryn R. Wagner, Monique M. Ryan, Scott Baker, A.D. Corbett, Baziel G.M. van Engelen, Stephen McNamara, Jean K. Mah,

Neuromuscular Disorders · 2016 · 11 citations · 24 references

DOI

Concepts

References

24

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Felicia Cosman, Suzanne M. Jan de Beur, Meryl S. LeBoff et al. · Osteoporosis International · 2014 · 4.1K citations · Full text

, , +16

A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy

Kathryn R. Wagner, James L. Fleckenstein, Anthony A. Amato et al. · Annals of Neurology · 2008 · 468 citations · Full text

, , +17

Loss of myostatin attenuates severity of muscular dystrophy in <i>mdx</i> mice

Kathryn R. Wagner, Alexandra C. McPherron, Nicole Winik et al. · Annals of Neurology · 2002 · 373 citations

, , +17

Neuromuscular Disease Causing Acute Respiratory Failure

Sangeeta Mehta · Respiratory Care · 2006 · 257 citations

, , +17

Myostatin Directly Regulates Skeletal Muscle Fibrosis

Zhao Bo Li, Helen D. Kollias, Kathryn R. Wagner · Journal of Biological Chemistry · 2008 · 256 citations · Full text

, , +17